A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial.
Verónica Gálvez OrtizPaul GlueAndrew A SomogyiDonel MartinAngelo AlonzoAnthony RodgersPhilip B MitchellAdrienne LiChristina HugginsColleen K LooPublished in: Journal of psychopharmacology (Oxford, England) (2019)